Search Results 2261-2270 of 21873 for platelets

1. LEGEND Study: A Phase 1/2 Study of EG-70 as an Intravesical Administration to Patients With BCG Unresponsive Non-Muscle Invasive Bladder Cancer (NMIBC) and High-Risk NMIBC Patients Who Are BCG Naïve or Received Incomplete BCG Treatment - Mayo Clinic

   Platelet count \>100,000/mm3. 10. Hepatic inclusion: 1. Total bilirubin must be ≤1.5 x the upper limit of normal (ULN). 2. Aspartate aminotransferase (AST) ...

2. Topical Cannabidiol (CBD) for the Treatment of Chemotherapy-induced Peripheral Neuropathy - Mayo Clinic

   Platelet count > 100,000/mm^3;; Absolute neutrophil count (ANC) ≥ 1,000/mm^3;; Hemoglobin > 11 g/dL;; Serum transaminase [ALT or AST] ≤ 1.2 x upper limit of ...

3. EORTC-1709-BTG_CCTG-CE.8: A Study to Compare Marizomib in Combination with Standard Radiochemotherapy vs. Radiochemotherapy Alone in Patients with Newly- diagnosed Glioblastoma MIRAGE - Mayo Clinic

   Platelet count of ≥ 100×10^9/L independent of transfusion;; Hemoglobin ≥ 10 g/dl;; Total Bilirubin ≤ 1.5 ULN;; ALT, AST, alkaline phosphatase (ALP) ≤ 2.5 ...

4. A Study to Evaluate the Effect of POSE2 on Long-term Gastric Motor Function - Mayo Clinic

   History of or current platelet or coagulation dysfunction, such as hemophilia. History or present use of insulin or insulin derivatives for treatment of ...

5. A Study to Evaluate Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer - Mayo Clinic

   Platelet count ≥ 100,000/mm³. Hemoglobin (Hgb) ≥ 8.0 g/dL (transfusion or other intervention to achieve Hgb ≥ 8.0 g/dL is acceptable). No prior invasive ...

6. Androgen Deprivation To Enrich PSMA Expression And Improve Sensitivity Of Staging PSMA PET/C - Mayo Clinic

   Platelet count ≥ 100,000/mm3. Male patients who are committed to undertaking the following measures for the duration of the study and after the last dose of ...

7. Combination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk Rhabdomyosarcoma - Mayo Clinic

   Platelet count ≥ 75,000/uL; Creatinine clearance or radioisotope glomerular filtration rate (GFR) ≥ 70 mL/min/1.73 m^2 or a serum creatinine based on age ...

8. A Study To Evaluate The Safety And Effectiveness Of Bimagrumab On Improvement In Total Lean Body Mass And Physical Performance Following Surgical Treatment Of Hip Fracture. - Mayo Clinic

   Significant coagulopathy, platelet count less than 75,000/mm3, or anemia (hemoglobin less than 8.0 g/dL); Active systemic infection requiring treatment with ...

9. Phase 1/2 Study of TP-0903 (an Inhibitor of AXL Kinase) in Patients With Previously Treated CLL - Mayo Clinic

   Platelet count ≥30,000/μL;; Hemoglobin ≥8 g/dL in the absence of transfusions within the previous 2 weeks. Have adequate organ function: Creatinine ...

10. A Study to Evaluate Non-Operative Management and Early Response Assessment in Rectal Cancer - Mayo Clinic

    - Platelets >100,000 cells/mm3 - Women of childbearing potential and men must agree to use adequate contraception (hormonal or barrier method of birth ...